HeartLungAI Press Releases

Published on February 19, 2025 - 12:00 GMT

SimonMed Imaging Partners with HeartLung.AI to Offer Artificial Intelligence-Based Bone Density Screening Nationwide

Dr. Simon's team at SimonMed Imaging chose HeartLung's AutoBMD™ AI to detect osteoporosis early, marking a significant milestone for both organizations HOUSTON, TX, UNITED STATES, February 19, 2025 /⁨EINPresswire.com⁩/ -- SimonMed Imaging and HeartLung Technologies are pleased to announce a strategic partnership to offer HeartLung's AI-enabled automated bone mineral density screening for opportunistic detection of bone loss (osteopenia and osteoporosis) in CT scans. This partnership marks a …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on January 28, 2025 - 16:00 GMT

HeartLung Technologies Welcomes World-Renowned Cardiologist Dr. Robert A. Kloner to the Advisory Board

HeartLung Technologies welcomes Dr. Robert A. Kloner to the Advisory Board. With over 45 years of experience, he brings unparalleled scientific leadership. HOUSTON, TX, UNITED STATES, January 28, 2025 /⁨EINPresswire.com⁩/ -- HeartLung Technologies is thrilled to announce the newest member of our Advisory Board, Dr. Robert A. Kloner, MD, PhD. With his extensive experience and pioneering research in cardiovascular health, Dr. Kloner will play a key role in shaping our future initiatives. His expertise will …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on November 30, 2024 - 18:47 GMT

HeartLung Technologies to Present Four Cutting-Edge Research Studies on AI-CAC™, AutoBMD™, and AI-CVD™ at RSNA 2024

HeartLung is the only AI company that is participating in RSNA 2024 both as a scientific presenter of multiple AI research studies and as an industry exhibitor HOUSTON, TX, UNITED STATES, November 30, 2024 /⁨EINPresswire.com⁩/ -- HeartLung Technologies (www.heartlung.ai), a leading developer of innovative AI solutions for early detection of heart disease, lung cancer, and other fatal conditions is pleased to announce that four of its scientific research studies on AI-CAC™, AutoBMD™, and AI-CVD™ have been …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on November 18, 2024 - 19:52 GMT

HeartLung Technologies Presented AI-CAC™ and AI-CVD™ Research Studies at the American Heart Association 2024 Conference

Innovative AI-enabled research studies led by HeartLung’s founder Dr. Morteza Naghavi show life-saving potential in primary prevention of cardiovascular disease CHICAGO, TX, UNITED STATES, November 18, 2024 /⁨EINPresswire.com⁩/ -- HeartLung Technologies is thrilled to announce that seven of its scientific research studies were presented at the 2024 Annual Scientific Sessions of the American Heart Association that coincided with the 100th anniversary of the Heart Association. The event, which took place …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on October 30, 2024 - 17:00 GMT

HeartLung Receives FDA “Breakthrough” Marketing Authorization for First AI to Detect Hidden Heart Disease in CT Scans

New AI flags enlarged heart chambers on non-con CT scans that are invisible to human eye and missed today leading to late-stage heart failure, Afib, and stroke. HOUSTON, TX, UNITED STATES, October 30, 2024 /⁨EINPresswire.com⁩/ -- innovative AI tools for early detection of heart disease, lung cancer, and other fatal conditions is pleased to announce that its AI-enabled Automated Cardiac Chambers Volumetry (AutoChamberTM) has received “Breakthrough Medical Device” designation and marketing authorization from …

Distribution channels: Business & Economy, Companies ...

The Newsroom of HeartLung Corporation

SimonMed Imaging Partners with HeartLung.AI to Offer Artificial Intelligence-Based Bone Density Screening Nationwide

HeartLung Technologies Welcomes World-Renowned Cardiologist Dr. Robert A. Kloner to the Advisory Board

HeartLung Technologies to Present Four Cutting-Edge Research Studies on AI-CAC™, AutoBMD™, and AI-CVD™ at RSNA 2024

HeartLung Technologies Presented AI-CAC™ and AI-CVD™ Research Studies at the American Heart Association 2024 Conference

HeartLung Receives FDA “Breakthrough” Marketing Authorization for First AI to Detect Hidden Heart Disease in CT Scans